Comparison/NN
of/IN
the/DT
transactivation/NN
domains/NNS
of/IN
Stat5/NN
and/CC
Stat6/NN
in/IN
lymphoid/JJ
cells/NNS
and/CC
mammary/JJ
epithelial/JJ
cells/NNS
./.

Stat/NN
(/(
signal/NN
transducers/NNS
and/CC
activators/NNS
of/IN
transcription/NN
)/)
and/CC
Jak/NN
(/(
Janus/NN
kinases/NNS
)/)
proteins/NNS
are/VBP
central/JJ
components/NNS
in/IN
the/DT
signal/NN
transduction/NN
events/NNS
in/IN
hematopoietic/JJ
and/CC
epithelial/JJ
cells/NNS
./.
=====
They/PRP
are/VBP
rapidly/RB
activated/VBN
by/IN
various/JJ
cytokines/NNS
,/,
hormones/NNS
,/,
and/CC
growth/NN
factors/NNS
./.
=====
Upon/IN
ligand/NN
binding/NN
and/CC
cytokine/NN
receptor/NN
dimerization/NN
,/,
Stat/NN
proteins/NNS
are/VBP
phosphorylated/VBN
on/IN
tyrosine/NN
residues/NNS
by/IN
Jak/NN
kinases/NNS
./.
=====
Activated/VBN
Stat/NN
proteins/NNS
form/VBP
homo-/JJ
or/CC
heterodimers/NNS
,/,
translocate/VBP
to/TO
the/DT
nucleus/NN
,/,
and/CC
induce/VBP
transcription/NN
from/IN
responsive/JJ
genes/NNS
./.
=====
Stat5/NN
and/CC
Stat6/NN
are/VBP
transcription/NN
factors/NNS
active/JJ
in/IN
mammary/JJ
epithelial/JJ
cells/NNS
and/CC
immune/JJ
cells/NNS
./.
=====
Prolactin/NN
activates/VBZ
Stat5/NN
,/,
and/CC
interleukin-4/NN
(/(
IL-4/NN
)/)
activates/VBZ
Stat6/NN
./.
=====
Both/DT
cytokines/NNS
are/VBP
able/JJ
to/TO
stimulate/VB
cell/NN
proliferation/NN
,/,
differentiation/NN
,/,
and/CC
survival/NN
./.
=====
We/PRP
investigated/VBD
the/DT
transactivation/NN
potential/NN
of/IN
Stat6/NN
and/CC
found/VBD
that/IN
it/PRP
is/VBZ
not/RB
restricted/JJ
to/TO
lymphocytes/NNS
./.
=====
IL-4-dependent/JJ
activation/NN
of/IN
Stat6/NN
was/VBD
also/RB
observed/VBN
in/IN
HC11/NN
mammary/JJ
epithelial/JJ
cells/NNS
./.
=====
In/IN
these/DT
cells/NNS
,/,
Stat6/NN
activation/NN
led/VBD
to/TO
the/DT
induction/NN
of/IN
the/DT
beta-casein/NN
gene/NN
promoter/NN
./.
=====
The/DT
induction/NN
of/IN
this/DT
promoter/NN
was/VBD
confirmed/VBN
in/IN
COS7/NN
cells/NNS
./.
=====
The/DT
glucocorticoid/NN
receptor/NN
was/VBD
able/JJ
to/TO
further/RB
enhance/VB
IL-4-induced/JJ
gene/NN
transcription/NN
through/IN
the/DT
action/NN
of/IN
Stat6/NN
./.
=====
Deletion/NN
analysis/NN
of/IN
the/DT
carboxyl-terminal/JJ
region/NN
of/IN
Stat6/NN
and/CC
recombination/NN
of/IN
this/DT
region/NN
with/IN
a/DT
heterologous/JJ
DNA/NN
binding/NN
domain/NN
allowed/VBD
the/DT
delimitation/NN
and/CC
characterization/NN
of/IN
the/DT
transactivation/NN
domain/NN
of/IN
Stat6/NN
./.
=====
The/DT
potencies/NNS
of/IN
the/DT
transactivation/NN
domains/NNS
of/IN
Stat5/NN
,/,
Stat6/NN
,/,
and/CC
viral/JJ
protein/NN
VP16/NN
were/VBD
compared/VBN
./.
=====
Stat6/NN
had/VBD
a/DT
transactivation/NN
domain/NN
which/WDT
was/VBD
about/RB
10-fold/RB
stronger/JJR
than/IN
that/DT
of/IN
Stat5/NN
./.
=====
In/IN
pre-B/JJ
cells/NNS
(/(
Ba/F3/NN
)/)
,/,
the/DT
transactivation/NN
domain/NN
of/IN
Stat6/NN
was/VBD
IL-4/NN
regulated/JJ
,/,
independently/RB
from/IN
its/PRP$
DNA/NN
binding/NN
function/NN
./.